Skip to main content

Drug Interactions between Cr-GTF and thyrotropin alpha

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

chromium picolinate thyrotropin alfa

Applies to: Cr-GTF (chromium picolinate) and thyrotropin alpha

Using thyrotropin alfa together with chromium picolinate may decrease the effects of thyrotropin alfa. You should separate the administration of chromium picolinate and thyrotropin alfa by taking thyrotropin alfa at least 30 minutes before chromium picolinate or by taking thyrotropin alfa 3 to 4 hours after taking chromium picolinate. If your doctor does prescribe these medications together, you may need a dose adjustment to safely use both medications. Contact your doctor if your condition changes or you experience symptoms of hypothyroidism such as dry skin, weight gain, cold intolerance, weakness, muscle cramps or stiffness, slow pulse, or constipation. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer